FOXK1 interaction with FHL2 promotes proliferation, invasion and metastasis in colorectal cancer

Oncogenesis

Volumn 5, Issue 11, 2016, Pages

  Wu, M ^a   Wang, J ^a   Tang, W ^a   Zhan, X ^a   Li, Y ^a   Peng, Y ^a   Huang, X ^a   Bai, Y ^a   Zhao, J ^a   Li, A ^a   Chen, C ^a   Chen, Y ^a   Peng, H ^a   Ren, Y ^a   Li, G ^a   Liu, S ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FOUR AND A HALF LIM PROTEIN 2; MESSENGER RNA; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FORKHEAD BOX K1; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CACO-2 CELL LINE; CANCER PROGNOSIS; CANCER TISSUE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LYMPH NODE METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ASSAY; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

EID: 85019380906     PISSN: None     EISSN: 21579024     Source Type: Journal    
DOI: 10.1038/oncsis.2016.68     Document Type: Article

References (36)

1. Weigel D, Jäckle H. The fork head domain: a novel DNA binding motif of eukaryotic transcription factors? Cell 1990; 63: 455–456.
2. Overdier DG, Porcella A, Costa RH. The DNA-binding specificity of the hepatocyte nuclear factor 3/forkhead domain is influenced by amino-acid residues adjacent to the recognition helix. Mol Cell Biol 1994; 14: 2755–2766.
3. Bassel-Duby R, Hernandez MD, Yang Q, Rochelle JM, Seldin MF, Williams RS. Myocyte nuclear factor, a novel winged-helix transcription factor under both developmental and neural regulation in striated myocytes. Mol Cell Biol 1994; 14: 4596–4605.
4. Wotton KR, Mazet F, Shimeld SM. Expression of Fox C, Fox F, Fox L1, and Fox Q1 genes in the dogfish Scyliorhinus canicula defines ancient and derived roles for Fox genes in vertebrate development. Dev Dyn 2008; 237: 1590–1603.
5. Leung TW, Lin SS, Tsang AC, Tong CS, Ching JC, Leung WY et al. Over-expression of FoxM1 stimulates cyclin B1 expression. FEBS Lett 2001; 507: 59–66.
6. Sturgill TW, Stoddard PB, Cohn SM, Mayo MW. The promoter for intestinal cell kinase is head-to-head with F-Box 9 and contains functional sites for TCF7L2 and FOXA factors. Mol Cancer 2010; 9: 104.
7. Jonsson H, Peng SL. Forkhead transcription factors in immunology. Cell Mol Life Sci 2005; 62: 397–409.
8. Freyaldenhoven BS, Fried C, Wielckens K. FOXD4a and FOXD4b, two new winged helix transcription factors, are expressed in human leukemia cell lines. Gene 2002; 294: 131–140.
9. Teh MT, Wong ST, Neill GW, Ghali LR, Philpott MP, Quinn AG. FOXM1 is a downstream target of Gli1 in basal cell carcinomas. Cancer Res 2002; 62: 4773–4780.
10. Millour J, Constantinidou D, Stavropoulou AV, Wilson MS, Myatt SS, Kwok JM et al. FOXM1 is a transcriptional target of ERalpha and has a critical role in breast cancer endocrine sensitivity and resistance. Oncogene 2010; 29: 2983–2995.
11. Sun H, Teng M, Liu J, Jin D, Wu J, Yan D et al. FOXM1 expression predicts the prognosis in hepatocellular carcinoma patients after orthotopic livertransplantation combined with the Milan criteria. Cancer Lett 2011; 306: 214–222.
12. Xia JT, Wang H, Liang LJ, Peng BG, Wu ZF, Chen LZ et al. Overexpression of FOXM1 is associated with poor prognosis and clinicopathologic stage of pancreatic ductal adenocarcinoma. Pancreas 2012; 41: 629–635.
13. Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature 2011; 474: 609–615.
14. Kim IM, Ackerson T, Ramakrishna S, Tretiakova M, Wang IC, Kalin TV et al. The Forkhead Box m1 transcription factor stimulates the proliferation of tumor cells during development of lung cancer. Cancer Res 2006; 66: 2153–2156.
15. Yoshida Y, Wang IC, Yoder HM, Davidson NO, Costa RH. The forkhead box M1 transcription factor contributes to the development and growth of mouse colorectal cancer. Gastroenterology 2007; 132: 1420–1431.
16. Shi X, Seldin DC, Garry DJ. Foxk1 recruits the Sds3 complex and represses gene expression in myogenic progenitors. Biochem J 2012; 446: 349–357.
17. Hawke TJ, Jiang N, Garry DJ. Absence of p21CIP rescues myogenic progenitor cell proliferative and regenerative capacity in Foxk1 null mice. J Biol Chem 2003; 278: 4015–4020.
18. Garry DJ, Meeson A, Elterman J, Zhao Y, Yang P, Bassel-Duby R et al. Myogenic stem cell function is impaired in mice lacking the forkhead/winged helix protein MNF. Proc Natl Acad Sci USA 2000; 97: 5416–5421.
19. Yang Q, Bassel-Duby R, Williams RS. Transient expression of a winged-helix protein, MNF-beta, during myogenesis. Mol Cell Biol 1997; 17: 5236–5243.
20. Wu Y, Peng Y, Wu M, Zhang W, Zhang M, Xie R et al. Oncogene FOXK1 enhances invasion of colorectal carcinoma by inducing epithelial-mesenchymal transition. Oncotarget (e-pub ahead of print 19 May 2016; doi: 10.18632/oncotarget.9457).
21. Chan KK, Tsui SK, Lee SM, Luk SC, Liew CC, Fung KP et al. Molecular cloning and characterization of FHL2, a novel LIM domain protein preferentially expressed in human heart. Gene 1998; 210: 345–350.
22. Wang J, Yang Y, Xia HH, Gu Q, Lin MC, Jiang B et al. Suppression of FHL2 expression induces cell differentiation and inhibits gastrointestinal carcinogenesis. Gastroenterology 2007; 132: 1066–1076.
23. Wei Y, Renard CA, Labalette C, Wu Y, Lévy L, Neuveut C et al. Identification of the LIM protein FHL2 as a coactivator of beta-catenin. J Biol Chem 2003; 278: 5188–5194.
24. Zhang W, Jiang B, Guo Z, Sardet C, Zou B, Lam CS et al. Four-and-a-half LIM protein 2 promotes invasive potential and epithelial-mesenchymal transition in colon cancer. Carcinogenesis 2010; 31: 1220–1229.
25. Ding L, Wang Z, Yan J, Yang X, Liu A, Qiu W et al. Human four-and-a-half LIM family members suppress tumor cell growth through a TGF-beta-like signaling pathway. J Clin Invest 2009; 119: 349–361.
26. Zhang W, Wang J, Zou B, Sardet C, Li J, Lam CS et al. Four and a half LIM protein 2 (FHL2) negatively regulates the transcription of E-cadherin through interaction with Snail1. Eur J Cancer 2011; 47: 121–130.
27. Yan Q, Zhang W, Wu Y, Wu M, Zhang M, Shi X et al. KLF8 promotes tumorigenesis, invasion and metastasis of colorectal cancer cells by transcriptional activation of FHL2. Oncotarget 2015; 6: 25402–25417.
28. Shi X, Bowlin KM, Garry DJ. Fhl2 interacts with Foxk1 and corepresses Foxo4 activity in myogenic progenitors. Stem Cells 2010; 28: 462–469.
29. Wang W, Li X, Lee M, Jun S, Aziz KE, Feng L et al. FOXKs promote Wnt/ß-catenin signaling by translocating DVL into the nucleus. Dev Cell 2015; 32: 707–718.
30. Scholl FA, McLoughlin P, Ehler E, de Giovanni C, Schäfer BW. DRAL is a p53-responsive gene whose four and a half LIM domain protein product induces apoptosis. J Cell Biol 2000; 151: 495–506.
31. Wang Q, Wang X, Tian X, Tang R, Xu X. Four and a half LIM domains 2 contributes to the development of human tongue squamous cell carcinoma. J Mol Histol 2016; 47: 105–116.
32. Yang Y, Hou H, Haller EM, Nicosia SV, Bai W. Suppression of FOXO1 activity by FHL2 through SIRT1-mediated deacetylation. EMBO J 2005; 24: 1021–1032.
33. Grant GD, Gamsby J, Martyanov V, Brooks L 3rd, George LK, Mahoney JM et al. Live-cell monitoring of periodic gene expression in synchronous human cells identifies Forkhead genes involved in cell cycle control. Mol Biol Cell 2012; 23: 3079–3093.
34. Turley EA, Veiseh M, Radisky DC, Bissell MJ. Mechanisms of disease: epithelial-mesenchymal transition—does cellular plasticity fuel neoplastic progression? Nat Clin Pract Oncol 2008; 5: 280–290.
35. Przybylo JA, Radisky DC. Matrix metalloproteinase-induced epithelial-mesenchymal transition: tumor progression at Snail's pace. Int J Biochem Cell Biol 2007; 39: 1082–1088.
36. Huber MA, Kraut N, Beug H. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 2005; 17: 548–558.